Lucid Diagnostics’ Initial Public Offering

Friedman Kaplan advised PAVmed Inc. and its majority-owned subsidiary Lucid Diagnostics Inc. on the public offering. Lucid Diagnostics Inc. (Nasdaq: LUCD),  a commercial-stage, cancer prevention medical diagnostics…

This content is for Standard 1 Year members only.
Login Join Now
Sonia Carcano

Author: Sonia Carcano

This content is for Standard 1 Year members only.
Login Join Now